Legal Affairs
Headset Settles Federal PPP Loan Claims
SEATTLE – Headset Inc. agreed to pay more than $1 ...
Delaware Announced the Launch Date for Legal Cannabis Sales
LOS ANGELES – The First State is about to make ...
The Hemp Surge: A Growing Challenge to Regulated Cannabis
NEW YORK — The legal line between hemp and cannabis ...
Compass Completes FDA Application for COMP360
LONDON / JERSEY CITY – Compass Pathways announced it has completed its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for COMP360, a synthetic psilocybin formulation, for treatment-resistant depression (TRD). If ...
Vireo Growth Reports Q3 2026 Financial Results
MINNEAPOLIS – Vireo Growth Inc. reported third-quarter revenue of $253.7 million, up 177% from $91.7 million a year earlier. Acquisitions drove the increase. Cannabis sales reached $198.1 million, and an agricultural supply business the company ...
Vireo Completes FLUENT Acquisition
MINNEAPOLIS – Vireo Growth Inc. has closed its acquisition of FLUENT Corp., absorbing the vertically integrated multi-state Cannabis operator through a court-approved arrangement. Under the final terms, Vireo acquired all issued and outstanding common shares ...
Compass Completes FDA Application for COMP360
LONDON / JERSEY CITY – Compass Pathways announced it has completed its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for COMP360, a synthetic psilocybin formulation, for treatment-resistant depression (TRD). If ...
Vireo Growth Reports Q3 2026 Financial Results
MINNEAPOLIS – Vireo Growth Inc. reported third-quarter revenue of $253.7 million, up 177% from $91.7 million a year earlier. Acquisitions drove the increase. Cannabis sales reached $198.1 million, and an agricultural supply business the company ...
Vireo Completes FLUENT Acquisition
MINNEAPOLIS – Vireo Growth Inc. has closed its acquisition of FLUENT Corp., absorbing the vertically integrated multi-state Cannabis operator through a court-approved arrangement. Under the final terms, Vireo acquired all issued and outstanding common shares ...
Village Farms Reports Q3 2026 Financial Results
VANCOUVER – Village Farms International Inc. reported record Cannabis revenue of $55 million for the third quarter, up 3% from a year earlier. The company generated consolidated sales of $66.9 million for the three months ...
Compass Completes FDA Application for COMP360
LONDON / JERSEY CITY – Compass Pathways announced it has completed its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for COMP360, a synthetic psilocybin formulation, for treatment-resistant depression (TRD). If ...
Vireo Growth Reports Q3 2026 Financial Results
MINNEAPOLIS – Vireo Growth Inc. reported third-quarter revenue of $253.7 million, up 177% from $91.7 million a year earlier. Acquisitions drove the increase. Cannabis sales reached $198.1 million, and an agricultural supply business the company ...
Vireo Completes FLUENT Acquisition
MINNEAPOLIS – Vireo Growth Inc. has closed its acquisition of FLUENT Corp., absorbing the vertically integrated multi-state Cannabis operator through a court-approved arrangement. Under the final terms, Vireo acquired all issued and outstanding common shares ...
Compass Completes FDA Application for COMP360
LONDON / JERSEY CITY – Compass Pathways announced it has completed its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for COMP360, a synthetic psilocybin formulation, for treatment-resistant depression (TRD). If ...
Vireo Growth Reports Q3 2026 Financial Results
MINNEAPOLIS – Vireo Growth Inc. reported third-quarter revenue of $253.7 million, up 177% from $91.7 million a year earlier. Acquisitions drove the increase. Cannabis sales reached $198.1 million, and an agricultural supply business the company ...
Vireo Completes FLUENT Acquisition
MINNEAPOLIS – Vireo Growth Inc. has closed its acquisition of FLUENT Corp., absorbing the vertically integrated multi-state Cannabis operator through a court-approved arrangement. Under the final terms, Vireo acquired all issued and outstanding common shares ...
Village Farms Reports Q3 2026 Financial Results
VANCOUVER – Village Farms International Inc. reported record Cannabis revenue of $55 million for the third quarter, up 3% from a year earlier. The company generated consolidated sales of $66.9 million for the three months ...
Cresco Labs Reports Q3 2026 Financial Results
CHICAGO – Cresco Labs Inc. announced third-quarter net revenue of $173 million, a 5% increase from the $165 million recorded during the same period last year and roughly unchanged from the second quarter. Retail sales ...
Canopy Growth Reports Q2 Fiscal 2027 Financial Results
SMITHS FALLS – Canopy Growth Corp. reported consolidated net revenue of CA$81.4 million for its fiscal second-quarter financial results ended September 30, 2026, up 22% from a year earlier. International Cannabis led the gain. Sales ...
TerrAscend Reports Q3 2026 Financial Results
TORONTO – TerrAscend Corp. reported net revenue of $68.2 million for the third quarter, up 4.8% from $65.1 million a year earlier. Gross margin edged up to 52.3% from 52.1%, based on Q3 2025 figures. ...
Nepal Greenlights Regulated Cannabis Cultivation
KATHMANDU – Nepal's Supreme Court has ordered the government to create a framework for the controlled cultivation and production of Cannabis for medicinal, scientific, agricultural, horticultural and industrial purposes. Officials have three months from receiving ...
Barney’s Farm Brings Cannabis Clones to U.S. Growers
WATSONVILLE – Barney's Farm announced that it has launched its Cannabis clone range for growers across the United States, introducing rooted Cannabis cuttings developed from selected mother plants at its California cultivation facility. The offering ...
Cronos Group Reports Q3 2026 Financial Results
TORONTO – Cronos Group Inc. reported record net revenue of $63.5 million, up 75% from a year earlier and 73% on an organic, constant-currency basis. Gross profit rose 76% to $32.3 million, a 50.9% margin. ...
Trulieve Reports Q3 2026 Financial Results
TALLAHASSEE – Trulieve Cannabis Corp. reported third-quarter revenue of $230.2 million, down 20% from a year earlier and 15% from the second quarter. Net income attributable to common shareholders was $0.9 million, compared with a ...
Aurora Shares Hit Ten-Month Highs on Organigram Bid
LOS ANGELES – Shares of Aurora Cannabis Inc. (ACB) surged more than 20% on both the NASDAQ and TSX, after Organigram Global Inc. (OGI) announced a definitive agreement to acquire the company for CA$7.80 per ...
RYTHM Reports Q3 2026 Financial Results
ROLLING MEADOWS – RYTHM, Inc. posted Q3 2026 revenue of $23.9 million, up 4% from the prior quarter and nearly six times its Q3 2025 figure. The company recorded a net loss of $533,000 alongside ...
GTI Reports Q3 2026 Financial Results
CHICAGO – Green Thumb Industries reported $324.4 million in revenue for the third quarter. Year-over-year growth of 11.3% was driven primarily by Minnesota retail sales following the state's adult-use launch in September 2025, along with ...
Democrats’ Historic Victory Could Accelerate Full Cannabis Legalization
WASHINGTON, D.C. –Democrats’ historic election victory could move Cannabis reform beyond medical rescheduling and put full federal legalization firmly back on the agenda. Democrats won Congress and gained ground in state governments, strengthening the opportunity ...
Curaleaf Presses Forward as Aurora Explores Rival Organigram Offer
STAMFORD – Curaleaf Holdings Inc. issued a pointed statement, acknowledging Aurora Cannabis's announcement of a competing arrangement agreement with Organigram Global Inc., and making clear it has no intention of standing down. Organigram, in its ...
Medical Cannabis Gets Its Federal Papers
LOS ANGELES – On October 30, the U.S. Department of Justice announced the DEA had issued federal registrations to more than 900 state-licensed medical Cannabis dispensaries across seven states: Alabama, Florida, Mississippi, South Dakota, Texas, ...
Curaleaf Reports Q3 2026 Financial and Operational Results
STAMFORD – Curaleaf Holdings Inc. posted third-quarter 2026 net revenue of $352.7 million with gains across both its domestic and international segments. Revenue grew 11% YoY and roughly 4% sequentially, extending three straight quarters of ...
Analysis: Higher THC Potency Doesn’t Always Correspond with More Pronounced Mood-Altering Effects
Melbourne, Australia: Doubling THC potency doesn’t necessarily lead to a corresponding increase in cannabis’ mood-altering effects, according to a review of 40 human studies published in the journal Neuroscience & Biobehavioral Reviews. Researchers from Australia, ...
Big Alcohol. Big Tobacco. What About Big Marijuana?
By Mark Collins | HCN Opinion When Democratic Texas U.S. Senate candidate James Talarico identified Big Alcohol and Big Tobacco as beneficiaries of restrictions on hemp-derived THC, he raised an important question: Who profits when ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Federal regulators drew a firm line around medical Сannabis, a hostile bid for Aurora turned more personal, and Q3 2026 earnings showed which operators convert retail traffic into cash. Capital deployment remains ...
DEA Bars Dual-Purpose Dispensaries From Federal Medical Cannabis Registration
WASHINGTON – In April, followed by Trump administration's rescheduling order, the U.S. Department of Justice announced that the DEA had granted federal registrations to more than 900 state-licensed medical Cannabis dispensaries in Alabama, Florida, Mississippi, ...
Cannabis Deals Multiply and Shrink in Q3 2026, Viridian Finds
LOS ANGELES – The Viridian Cannabis Deal Tracker counted 74 transactions in the third quarter: 28 in M&A, 27 in equity and 19 in debt. That is the most in any quarter since early 2023 ...
AJNA Biosciences Files for DEA Authorization to Grow Cannabis Under FDA Drug Framework
LITTLETON – AJNA Biosciences, a botanical drug development company, applied to the DEA for registration as a bulk manufacturer of Schedule I controlled substances. The filing, made available for public inspection on 30 October and ...
Optimi Goes Down Under with New Australian Subsidiary
VANCOUVER / SYDNEY – Optimi Health Corp., a commercial-stage pharmaceutical developer and manufacturer of regulated psychedelic drug products, announced the establishment of Optimi Australia Pty Ltd, a wholly owned subsidiary responsible for distribution and business ...
